tiprankstipranks
Trending News
More News >
CASI Pharmaceuticals receives proposal to acquire China business for $20M
PremiumThe FlyCASI Pharmaceuticals receives proposal to acquire China business for $20M
7d ago
CASI Pharmaceuticals Reports 2024 Financial Results and Strategic Developments
Premium
Company Announcements
CASI Pharmaceuticals Reports 2024 Financial Results and Strategic Developments
10d ago
Casi Pharmaceuticals reports Fy24 EPS ($2.56) vs. ($2.02) last year
Premium
The Fly
Casi Pharmaceuticals reports Fy24 EPS ($2.56) vs. ($2.02) last year
10d ago
CASI Pharmaceuticals Faces Clinical Hold on CID-103 by FDA
PremiumCompany AnnouncementsCASI Pharmaceuticals Faces Clinical Hold on CID-103 by FDA
4M ago
Casi Pharmaceuticals files $200M mixed securities shelf
Premium
The Fly
Casi Pharmaceuticals files $200M mixed securities shelf
4M ago
CASI Pharmaceuticals Faces Evomela® License Termination Dispute
Premium
Company Announcements
CASI Pharmaceuticals Faces Evomela® License Termination Dispute
4M ago
Casi Pharmaceuticals receives CTA approval from China NMPA for CID-103
PremiumThe FlyCasi Pharmaceuticals receives CTA approval from China NMPA for CID-103
6M ago
CASI Pharmaceuticals Revamps Management Structure
Premium
Company Announcements
CASI Pharmaceuticals Revamps Management Structure
7M ago
Casi Pharmaceuticals files to sell 3M ordinary shares for holders
Premium
The Fly
Casi Pharmaceuticals files to sell 3M ordinary shares for holders
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100